RECURRENT OVARIAN CARCINOSARCOMA
Clinical trials for RECURRENT OVARIAN CARCINOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OVARIAN CARCINOSARCOMA trials appear
Sign up with your email to follow new studies for RECURRENT OVARIAN CARCINOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine combo aims to outsmart recurrent ovarian cancer
Disease control Recruiting nowThis study tests a new treatment for ovarian cancer that has returned after initial therapy. It combines a personalized vaccine made from a patient's own white blood cells (FRalphaDC) with an immunotherapy drug (pembrolizumab). The goal is to safely boost the immune system to rec…
Matched conditions: RECURRENT OVARIAN CARCINOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 03:27 UTC
-
Ovarian cancer Patients' own immune cells supercharged to fight tumors
Disease control Recruiting nowThis early-phase study tests a new treatment for ovarian cancer that has come back or not responded to standard therapy. Doctors take a patient's own immune cells (T cells), train them in a lab to recognize a protein called MUC1 found on cancer cells, and then give them back to t…
Matched conditions: RECURRENT OVARIAN CARCINOSARCOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 22, 2026 13:54 UTC